Trials / Unknown
UnknownNCT03046407
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 55 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This project intends to transplant human embryonic stem cells derived retinal pigment epitheliums into subretinal space of patients to treat dry age-related macular degeneration(dry-AMD).And we will assess the safety and efficacy of RPE transplants to treat dry AMD.
Detailed description
This project intends to transplant human embryonic stem cells derived retinal pigment epitheliums into subretinal space of patients to treat dry age-related macular degeneration(dry-AMD). Through the statistical analysis EDTRS, BCVA, OCT, ERG, Fluorescein angiography, Ophthalmic AB ultrasound changes between before and after the treatment to assess the safety and efficacy of RPE transplants to treat dry AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | retinal pigment epithelium transplantation | Transplant retinal pigment epithelium derived from human embryonic stem cells into subretinal space of patients with dry age-related macular degeneration(dry AMD). |
Timeline
- Start date
- 2017-09-06
- Primary completion
- 2019-01-01
- Completion
- 2020-12-01
- First posted
- 2017-02-08
- Last updated
- 2018-01-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03046407. Inclusion in this directory is not an endorsement.